The Rutherford Cancer Centre Thames Valley offers patients the latest in advanced cancer treatment technologies including facilities for radiotherapy, infusion therapies and up-to-date imaging services. Our range of oncology services is open to both children and adults and tailored specifically to our patient's clinical needs. Proton beam therapy will be available at our Thames Valley centre from late 2019
The centre is located at:
Rutherford Cancer Centre Thames Valley, 3 Collegiate Square, Shinfield, Reading, RG2 9LH
All of our registered centres undergo a registration inspection by the independent healthcare regulators of each country (Healthcare Inspectorate Wales, Care Quality Commission) to ensure that the quality and safety of services meet the required standards of care. In addition, ongoing inspections are undertaken and where these have taken place, full reports are made available on our website.
Currently under construction and scheduled to open in 2019, the Rutherford Cancer Centre North West will provide a hub for specialist cancer treatment including state-of-the-art imaging facilities, radiotherapy, chemotherapy, wellbeing and support services, in addition to proton beam therapy which will be available from early 2020.
Find out more View this location on mapRutherford Cancer Centre North East was custom built to suit the needs of our patients, offering the latest in diagnostic technology and treatments including radiotherapy and chemotherapy, in addition to wellbeing services. Proton beam therapy is coming soon to Rutherford Cancer Centre North East and will be available from mid-2019.
Find out more View this location on mapRutherford Cancer Centre South Wales was the first of our centres to open in the UK and the first UK Cancer Centre to offer high energy proton beam therapy. This centre offers patients state-of-the-art radiotherapy, imaging and chemotherapy using the latest in cancer treatment and diagnostic technology alongside our holistic supportive care.
Find out more View this location on map© Proton Partners International Ltd